PHAT
Phathom Pharmaceuticals Inc
NASDAQ: PHAT · HEALTHCARE · BIOTECHNOLOGY
$11.20
-4.92% today
Updated 2026-04-30
Market cap
$935.69M
P/E ratio
—
P/S ratio
5.34x
EPS (TTM)
$-3.03
Dividend yield
—
52W range
$2 – $18
Volume
1.2M
Phathom Pharmaceuticals Inc (PHAT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.02M | $-36.51M | $-69.69M | $-148.46M | $-146.53M | $-137.58M | $-266.77M | $-166.78M |
| Capital expenditures | $132000.00 | $25.25M | $1.04M | $328000.00 | $1.04M | $1.63M | $135000.00 | $229000.00 |
| Depreciation | $8000.00 | $8000.00 | $323000.00 | $521000.00 | $620000.00 | $575000.00 | $795000.00 | — |
| Stock-based comp | — | $406000.00 | $5.84M | $16.81M | $24.13M | $45.02M | $24.05M | $28.72M |
| Free cash flow | $-1.16M | $-61.76M | $-70.73M | $-148.78M | $-147.57M | $-139.21M | $-266.90M | $-167.00M |
| Investing cash flow | $-25.25M | $-25.25M | $-1.04M | $-328000.00 | $-1.04M | $-1.63M | $-135000.00 | — |
| Financing cash flow | $1.90M | $304.65M | $114.46M | $44.71M | $120.04M | $367.58M | $182.77M | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $43.73M | $-104.24M | — | — | — | — |